Latasha Lee, Phd, Mph Email & Phone Number

The lead on US patient advocacy for the hemoglobinopathies program (including sickle cell disease and beta thalassemia), where she is responsible for developing and executing the broader hemoglobinopathies alliance strategy, ensuring alignment with disease area objectives, and collaborating closely with key internal partners, disease area leaders, and.

Washington D.C. Metro Area

Dr. Lee is an Adjunct Assistant Professor in the Medical Laboratory Sciences (MLS) and Health Sciences (HSCI) Programs at the George Washington University School of Medicine and Health Sciences. She has over a decade of experience in teaching and research, ranging from cancer biology and neuroscience to public health and assay development. Within the MLS.

Washington, District Of Columbia, United States

LaTasha is responsible for directing and implementing the NMQF's research and development policies, objectives, studies, and initiatives. In that role she is focused on ensuring that research and development activities will uphold the organization's mission and vision, while maintaining it's competitive position and credibility.

Washington D.C. Metro Area

In her role in the newly established ASH Sickle Cell Disease Clinical Trials Network (SCD CTN) Department, LaTasha was responsible for establishing, implementing, and maintaining effective partnerships with stakeholders including academic medical centers, other clinical research sites, sickle cell disease patients, industry, and federal agencies regarding.

Washington D.C. Metro Area

Staff member of the American Society of Hematology's Government Relations and Practice Department, working very closely with ASH and Congressional staff to keep a pulse of what is happening on Capitol Hill and in the federal agencies related to biomedical research, Medicare physician payment, drug shortages, or other advocacy-related issues of interest to.

Washington D.C. Metro Area

• Evaluate and develop legislation related to healthcare and health systems delivery
• Work with the Senate Finance Committee Health Staff on Medicare, Medicaid, and related health issues
• Participate in the Chronic Care Working Group to develop bipartisan solutions that improve health outcomes for Medicare patients with chronic conditions
• Meet with constituents and interest groups; engage stakeholder groups for feedback on legislative initiatives/priorities
• Research legislative issues and draft legislation or resolutions
• Prepare memorandums on relevant health policy topics or briefings

Washington D.C. Metro Area

Jupiter, FL

• Characterization of a conserved genes relevant to neurological disorders and diseases using D. melanogaster as a model organism
• Examined potential transcriptional effects on cell adhesion molecules involved in neurodevelopment using molecular, genetic, and electrophysiological techniques (Western Blot, QT RT PCR, knockdown, cell autonomous.
• Executed genetic screen for suppressors of a mutant phenotype in the giant fiber system
• Characterized a novel developmental role of a protein tyrosine phosphatase (PTP69D) in the giant fiber (GF) neurons revealing a role in synaptic terminal growth in the central nervous system
• Collaborated with international team of neuro and biomedical scientists to characterize mutations in Charcot Marie Tooth (CMT) disease

Responsible for hiring, supervision, and performance review of 12 staff members across 5 campuses; managed numerous programs and projects of the organization (20+ widely attended events annually); oversaw a $350,000+ annual budget; worked with a multidisciplinary team to formulate a strategic plan both for the department and the university; served on.

Tampa, Florida

As a research assistant in the Cancer Control Division I worked with a team to develop a novel assay approach to increase the accuracy of early lung cancer detection. This assay utilized nanotechnology and a micro-fluidic platform to detect either optically or by anelectrochemical bio-sensor biomarkers of lung cancer. This work led several publications.

Indianapolis, Indiana Area

In the Lilly Infectious Diseases division I was responsible for employing the use of biomedical science techniques and critical thinking to develop and test a novel technique of cosmid DNA pooling in a target species, A. nidulans, for rapid identification of targeted cosmids for drug development.

Doctor Of Philosophy (Ph.D.), Neurobiology And Neurosciences

Master’S Degree, Public Health

Bachelor’S Degree, Biology/Biological Sciences, General